China, Aug. 13 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Screening for Primary Aldosteronism in Fengxian'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600129973
Registration Time: 2026/08/12
Type: Observational study
Primary Sponsor: Shanghai Fengxian District Central Hospital
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=333221
Published by HT Digital Content Services with permission from Health Daily Digest....